[ad_1] Recently, new drugs developed by Korean pharmaceutical companies have been designated as rare drugs by the US Food and Drug Administration (FDA). It is a beachhead for Korean drugs to accelerate …
Read More »美 FDA, 기면증 치료제 '자이 렘' 소아 적응증 추가
[ad_1] F 식품 의 약국 (FDA) 이 재즈 파마슈티컬스 (Jazz Pharmaceuticals) 의 자이 렘 (Xyrem, sodium oxybate) 을 소아 기면증 환자 를 를 를 치료제 치료제 승인 승인 했다 했다. FDA 가 …
Read More »FDA Approves First Malaria Treatment for 60 Years (Three Days)
[ad_1] Possible to eradicate "recurrent" malaria … Undesirable side effects are also significant The first recurrence of malaria in the world, which affects 8.5 million people a year, has been approved in …
Read More »[제약/바이오] FDA Announces Guidelines for the Development of Gene Therapy Products
[ad_1] [TY’s Pick] – Compbad for the development of gene therapy On June 11, FDA Director Scott Gottlieb released a draft directive on the development of gene therapy products. In addition to …
Read More »